Considering the immunocompromised state of T-lymphopenic mice, we opted for the MC38 colon carcinoma graft model, known for its immunogenicity and responsiveness to anti-PD-1 treatment (49, 50). The gene discussed is PDCD1; the disease is colon carcinoma.